Related Experiment Videos

Haemoglobin A1: An indicator of the metabolic control of diabetic patients

Lancet (London, England)
|October 8, 1977
PubMed

Insights

Glycosylated hemoglobin (HbA1) levels accurately reflect diabetes control in patients. This simple test helps screen for uncontrolled diabetes and assess treatment effectiveness.

Area of Science:

  • Clinical Chemistry
  • Endocrinology
  • Diabetes Management

Background:

  • Glycosylated hemoglobin (HbA1) is a key biomarker in diabetes management.
  • Assessing long-term glycemic control is crucial for preventing diabetic complications.

Purpose of the Study:

  • To evaluate the correlation between HbA1 levels and clinical assessments of diabetes control.
  • To determine the utility of HbA1 as a tool for monitoring diabetes management.

Main Methods:

  • Measurement of minor glycosylated haemoglobins (HbA1) in ambulatory and hospitalized diabetic patients.
  • Correlation analysis with physician ratings of diabetes control and various plasma glucose measurements (fasting, mean, highest daily).

Main Results:

  • HbA1 levels showed a close correlation with physician assessments of diabetes control in ambulatory patients.
  • Significant correlations were observed between HbA1 and mean fasting, mean daily, and highest daily glucose values in hospitalized patients.
  • HbA1 measurement is a simple, rapid, and objective method for assessing glycemic control.

Conclusions:

  • HbA1 is a reliable indicator of long-term glycemic control in diabetic patients.
  • HbA1 measurement can serve as a valuable screening tool for uncontrolled diabetes.
  • This biomarker effectively indicates the efficacy of different therapeutic strategies for diabetes management.

Related Concept Videos